Mussaa Healthcare Research And Development Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
- Revenue Growth -37.56%
- Profit Growth 68.34%
- Ebitda 59.53%
- Net Worth -13.64%
- Total Assets -13.19%
About Mussaa Healthcare Research And Development
Mussaa Healthcare Research And Development Private Limited (MHRADPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2012 and has a history of 12 years and nine months. Its registered office is in Anantnag, Jammu & Kashmir.
The Corporate was formerly known as Mussaa Health Care Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Aadil Jan and Nisara Khan serve as directors at the Company.
Company Details
-
LocationAnantnag, Jammu & Kashmir
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100JK2012PTC003527
-
Company No.
003527
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Apr 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jammu
Industry
Who are the key members and board of directors at Mussaa Healthcare Research And Development?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aadil Jan | Director | 16-Apr-2012 | Current |
Nisara Khan | Additional Director | 26-Jun-2018 | Current |
Financial Performance of Mussaa Healthcare Research And Development.
Mussaa Healthcare Research And Development Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 37.56% decrease. The company also saw a substantial improvement in profitability, with a 68.34% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mussaa Healthcare Research And Development?
In 2016, Mussaa Healthcare Research And Development had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
15 Feb 2013 | State Bank Of India | ₹6.00 M | Open |
How Many Employees Work at Mussaa Healthcare Research And Development?
Unlock and access historical data on people associated with Mussaa Healthcare Research And Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mussaa Healthcare Research And Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mussaa Healthcare Research And Development's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.